Nutex Health Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Nutex Health Inc. (NUTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income52.10-45.79-424.78132.59105.97
Depreciation & Amortization18.9717.5913.137.665.90
Deferred Income Tax-13.13-5.715.00-0.980.00
Stock Based Compensation16.552.840.190.000.00
Change in Working Capital-103.85-1.6664.322.75-66.02
Change in Accounts Receivable-173.41-4.5858.08-6.62-71.23
Change in Inventory0.540.14-0.72-1.09-0.83
Change in Accounts Payable15.81-2.259.696.276.23
Change in Other Working Capital1.115.03-2.734.20-0.19
Other Operating Activities1.11-3.15-2.3430.3740.76
Net Cash from Operating Activities23.151.2650.61173.4386.67
Investing Activities
Capital Expenditures-2.30-9.50-14.63-36.93-61.19
Acquisitions-0.36-0.7012.723.880.00
Purchases of Investments-2.940.000.000.000.00
Sales/Maturities of Investments0.000.0012.724.070.00
Other Investing Activities0.000.0012.72-0.490.00
Net Cash from Investing Activities-5.61-11.24-4.34-36.98-61.19
Financing Activities
Debt Repayment-16.68-21.56-9.03-22.84-16.91
Common Stock Issued9.200.309.2821.7510.03
Dividends Paid-6.44-5.21-34.35-111.69-45.63
Other Financing Activities3.35-5.21-17.47-32.69-13.63
Net Cash from Financing Activities1.09-2.27-48.13-125.85-7.97
Summary
Net Change in Cash18.64-12.25-1.8610.6017.51
Cash at Beginning of Period22.0034.2636.1225.510.00
Cash at End of Period40.6422.0034.260.030.00
Free Cash Flow20.85-8.2435.97136.5125.48
Supplemental Disclosures
Interest Paid3.471.644.624.103.25
Income Taxes Paid0.800.858.230.340.18